Product Categories
| Country: | China |
|---|---|
| Tel: | 021-64543801 |
| Mobile: | 13764082696 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-methyl-pyrimidine-4,6-diamine | C5H8N4 | 197165-78-9 | Details |
| Urocortin III (mouse) | C186H312N52O52S2 | 357952-10-4 | Details |
| 2-Chloropyridium triflate on Wang resin | Details |
| 2-(4-chloro-benzylamino)-nicotinic acid | C13H11ClN2O2 | 33522-81-5 | Details |
| 3-carbamoyl-1-(2,4,6-trimethylbenzyl)pyridinium chloride | C16H19ClN2O | 87384-53-0 | Details |
| 1,2-epoxy-3-(indol-4-yloxy)propane | C11H11NO2 | 35308-87-3 | Details |
| 2-(benzimidazol-2-yl)pyrimidine | C11H8N4 | 18107-02-3 | Details |
| H-Trp-Lys-OH | C17H24N4O3 | 51790-14-8 | Details |
| rec Neutrophil-Activating Peptide-2 (human) | Details |
| β-Lipotropin (1-10) (porcine) | C42H66N10O15 | 77875-68-4 | Details |
| H-Gly-Cys-OH | C5H10N2O3S | 57281-78-4 | Details |
| 1-(5-Benzylidene-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione)-4-boronic acid pinacol ester | Details |
| 2,3-di(p-tolyl)pyridine | C19H17N | 181883-10-3 | Details |
| methyl 3-[(5-nitropyridin-2-yl)oxy]benzoate | C13H10N2O5 | 875701-23-8 | Details |
| Z-D-Val-OSu | C17H20N2O6 | 4467-55-4 | Details |
| (Acetonitrile)trichlorobis(triphenylphosphine)rhenium(III) | 2C18H15P.C2H3N.Cl3Re | 34387-57-0 | Details |
| [(2R,4R,5S)-2-Benzyl-5-(Boc-amino)-4-hydroxy-6-phenyl-hexanoyl]-Leu-Phe-NH2 | C39H52N4O6 | 292632-98-5 | Details |
| Boc-Phe-Phe-OH | C23H28N2O5 | 13122-90-2 | Details |
| H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH | C41H61N13O15S2 | 166184-23-2 | Details |
| 2,6-diamino-4-oxo-1,4-dihydropyrimidin-5-yl hydrogen sulfate | C4H6N4O5S | 51170-90-2 | Details |
| N4-(4-chloro-phenyl)-6-methyl-pyrimidine-2,4-diamine | C11H11ClN4 | 7752-45-6 | Details |
| (2-chloropyridin-3-yl)-(4-fluorobenzyl)amine | C12H10ClFN2 | 906371-80-0 | Details |
| FGF acidic (1-11) (bovine brain) | C62H95N15O15 | 211362-82-2 | Details |
| Hirudin | C285H447N81O107S6 | 120300-65-4 | Details |
| Orexin B (human) | C123H212N44O35S | 205640-91-1 | Details |
| Praseodymium(III) bromide anhydrous, powder | Br3Pr | 13536-53-3 | Details |
| pTH (73-84) (human) | C54H96N16O19 | 321957-35-1 | Details |
| [2-(1-Piperidinylmethyl)phenyl]magnesium bromide solution 0.25M in THF | C6H4CH2NC5H10MgBr | 480424-81-5 | Details |
| D-Lanthionine | C6H12N2O4S | 922-56-5 | Details |
| Bz-Val-Gly-Arg-pNA | C26H34N8O6 | 64717-41-5 | Details |
| H-Orn-AMC | C15H19N3O3 | 98516-75-7 | Details |
| pTH (1-38) (human) | 78232-94-7 | Details |
| 2-bromo-4-(dibromomethyl)pyridine | C6H4Br3N | 865449-19-0 | Details |
| H-Tyr-Thr-Lys-OH | C19H30N4O6 | 168971-88-8 | Details |
| Z-His(Z)-ONp | C28H24N4O8 | Details |
| 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl | C33H49P | 564483-18-7 | Details |
| H-Leu-Trp-Met-Arg-OH | C28H44N8O5S | 67368-23-4 | Details |
| H-Ile-βNA | C16H20N2O | 732-84-3 | Details |
| Iron(III) sulfate hydrate 97% | FeH4O5S | 15244-10-7 | Details |
| Benzyldiphenylphosphine | C19H17P | 7650-91-1 | Details |
| 3-hydroxy-pyridine-2-sulfonic acid | C5H5NO4S | 88511-41-5 | Details |
| Angiotensin II Antipeptide | C42H62N10O12 | 121379-63-3 | Details |
| H-m-Fluoro-D-Phe-OMe HCl | C10H13ClFNO2 | 201479-09-6 | Details |
| 2-amino-3-(2-fluorobenzyloxy)pyridine | C12H11FN2O | 79707-17-8 | Details |
| D-Nle-Obzl.TOS | Details |
| H-Asp-βNA | C14H14N2O3 | 635-91-6 | Details |
| Anxiety Peptide | C81H138N24O29 | 95237-86-8 | Details |
| 3-Bromo-2-butoxy-5-fluorophenylboronic acid | C10H13BBrFO3 | 352534-85-1 | Details |
| Allyl[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloropalladium(II) 98% | C30H41ClN2Pd | 478980-03-9 | Details |
| H-Tyr-Phe-OH | C18H20N2O4 | 17355-11-2 | Details |
| H-Pro-Ile-OH | C11H20N2O3 | 51926-51-3 | Details |
| Z-Sar-Met-OH | C16H22N2O5S | Details |
| Acetyl-(Ala10 | C69H95N15O24 | 838825-26-6 | Details |
| 6-Bromo-2,3-difluorophenylboronic acid | C6H4BBrF2O2 | 870718-10-8 | Details |
| Bovine Pineal Antireproductive Tripeptide | C13H26N4O6 | 71730-64-8 | Details |
| 1-(4-(methylthio)phenyl)-2-(3-methyl-2-pyridyl)acetylene | C15H13NS | 1019322-08-7 | Details |
| 5-(prop-2-ynynloxy)indole | C11H9NO | 153969-91-6 | Details |
| Methyll-bromo-cyclopropanecarboxylate | C5H7BrO2 | 96999-01-8 | Details |
| 3-chloro-N-(4-nitrophenyl)pyridin-2-amine | C11H8ClN3O2 | 370571-30-5 | Details |
| Z-Val-Gly-Phe-OH | C24H29N3O6 | 138867-42-2 | Details |
| Human CMV Assemblin Protease Substrate (M-site) | C52H96N20O16 | Details |
| Tropoelastin Fragment | C23H38N6O7 | Details |
| Z-Ser(Trt)-OH | C30H27NO5 | 1330286-53-7 | Details |
| Kyotorphin | C15H23N5O4 | 70904-56-2 | Details |
| Propylmagnesium chloride solution 2.0 M in diethyl ether | C3H7ClMg | 2234-82-4 | Details |
| 2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one | C9H10N2O2 | 20348-21-4 | Details |
| Cholecystokinin Octapeptide (1-2) (desulfated) | C13H16N2O6 | 22840-03-5 | Details |
| Bpoc-Ala-OH | C19H21NO4 | 23631-89-2 | Details |
| H-Gly-D-Val-OH | C7H14N2O3 | 10521-49-0 | Details |
| Kinetensin | C56H85N17O11 | 103131-69-7 | Details |
| Bis(cyclopentadienyl)vanadium(II) | C10H10V10* | 1277-47-0 | Details |
| H-Met-Cys-Glu-Lys-OH | C19H35N5O7S2 | 319438-96-5 | Details |
| Bz-Lys-OMe HCl | C14H21ClN2O3 | 14280-01-4 | Details |
| H-Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala-OH | C39H72N16O12 | 81117-26-2 | Details |
| Nesfatin-1 (human) | 917528-35-9 | Details |
| N-(1H-benzimidazol-1-ylmethyl)-3-pyridinecarboxamide | C14H12N4O | 404965-38-4 | Details |
| H-Trp-Val-OMe | C17H24ClN3O3 | 92410-11-2 | Details |
| Fmoc-ε-azido-Nle-OH | C21H22N4O4 | 159610-89-6 | Details |
| Palladium pivalate 97% | Pd[O2C(CH3)3]2 | 106224-36-6 | Details |
| N-Me-D-Phe-OH | C10H13NO2 | 56564-52-4 | Details |
| Lys-(Des-Arg9)-Bradykinin | C50H73N13O11 | 71800-36-7 | Details |
| 2,4,6-Trimethylphenylboronic acid | C9H13BO2 | 5980-97-2 | Details |
| Nickel(II) bromide ethylene glycol dimethyl ether complex | C4H10Br2NiO2 | 28923-39-9 | Details |
| H-Gly-Arg-Asp-Gly-Ser-OH | C17H30N8O9 | 99131-38-1 | Details |
| Fmoc-m-fluoro-Phe-OH | C24H20FNO4 | 198560-68-8 | Details |
| 3-Bromo-2-(2′-fluorobenzyloxy)-5-methylphenylboronic acid | C14H13BBrFO3 | 849062-18-6 | Details |
| 2-cyclobutoxy-5-nitro-pyridine | C9H10N2O3 | 916610-34-9 | Details |
| 2-amino-5-cyano-pyridine | C6H5N3 | 4214-73-7 | Details |
| 5-bromo-2-(1-methyl-2-propenyloxy)pyrimidine | C8H9BrN2O | 123089-12-3 | Details |
| 1-(4-chlorobenzo[d]thiazol-2-yl)-3-(5-bromopyridin-2-yl)urea | C13H8BrClN4OS | 1072849-89-8 | Details |
| Human Parainfluenza Virus Type 3 Fusion Protein (454-488) (acetylated) | C183H294N54O59 | 174881-94-8 | Details |
| H-DL-Ala-OEt HCl | C5H11NO2 | 17344-99-9 | Details |
| Extracellular Death Factor | C27H36N10O10 | 960129-66-2 | Details |
| (Met5,Pro6,D-Phe7,D-Trp9,Phe10)-α-MSH (5-13) | Details |
| naphthalene-2-carboxylic acid (5-chloro-pyridin-2-yl)-amide | C16H11ClN2O | 258338-52-2 | Details |
| Tos-Lys(Boc)-OH | C18H28N2O6S | 16948-09-7 | Details |
| Nickel(II) sulfate hexa-/ heptahydrate for nickel plating | NiO4S | 15244-37-8 | Details |
| H-Arg(NO2)-OBzl p-tosylate salt | C13H19N5O4 | 7672-27-7 | Details |
| (1H-indol-5-yl)-carbamic acid tert-butyl ester | C13H16N2O2 | 184031-16-1 | Details |
| Tungsten(0) pentacarbonyl-N-pentylisonitrile | C6H11N.5CO.W | 347145-09-9 | Details |
| Product Total： Product Page： | ||||
| 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 | ||||